Furthermore, TGF-β2 can inhibit the inflammatory response in immature human intestinal epithelial cells and suppress the expression of macrophage cytokines, thereby reducing the risk of necrotizing enterocolitis (NEC) in preterm neonates [15,16,17]. Here, TGFB2 is linked to necrotizing enterocolitis.